Doxycycline for post-exposure prophylaxis of anthrax : emergency use instructions for healthcare providers

Details

• Alternative Title:
  Doxycycline for post-exposure prophylaxis of anthrax : eui for healthcare providers ; Doxycycline EUI for Healthcare Providers
• Corporate Authors:
  Centers for Disease Control and Prevention (U.S.)
• Description:
  Doxycycline EUI for Healthcare Providers (originally issued 03/28/2016; revised 08/18/2017) ; This fact sheet provides instructions for the use of doxycycline for post‐exposure prophylaxis (PEP) during an emergency involving anthrax (referred to as Emergency Use Instructions (EUI) fact sheet). Doxycycline is FDA‐approved for PEP of inhalation anthrax – to reduce the incidence or progression of disease following exposure to aerosolized Bacillus anthracis (B. anthracis). The Food and Drug Administration (FDA) has also issued an order permitting the emergency dispensing of oral formulations of doxycycline without a prescription during an anthrax emergency to individuals who may have been exposed to B. anthracis. ; doxy-eui-hcp-H.pdf
• Subjects:
  • Anthrax
  • Doxycycline
  • Emergencies
  • Post-Exposure Prophylaxis
• Document Type:
  Pamphlet (or booklet)
• Genre:
  Guidance
• Pages in Document:
  2 numbered pages
• Download URL:
  https://stacks.cdc.gov/view/cdc/56836/cdc_56836_DS1.pdf
• File Type:
  [PDF - 191.96 KB]
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha256:6e2c8f0172dc9462efe3c491bc6a169d5acd29009e36063d6c1a3ee969deea58